Digital Precision Medicine in Practice: Newel Health joins Frontiers Health 2025 as Strategic Partner
We are delighted to welcome Newel Health as a Strategic Partner at Frontiers Health 2025.
Newel Health develops AI-driven Software as a Medical Device (SaMD) for chronic disease management, with a CE-marked portfolio spanning cardiometabolic conditions, neuroscience, and pain. The company collaborates with pharmaceutical and medtech partners to co-develop AI-enabled digital biomarkers, clinically validated digital endpoints, and regulatory-grade companion apps. All solutions are built on H.Core, Newel Health’s platform that transforms real-world data into adaptive, personalized interventions — bringing digital precision medicine into clinical practice and supporting evidence generation, reimbursement strategies, and scalable commercialization across European health systems.
At Frontiers Health 2025:
- Ervin Ukaj, CEO of Newel Health, will speak on The Future of Patient-Centric Care during the Innovation Ecosystem Gathering.
- Silja Voolma, Strategy & Growth Lead at Newel Health, will join the Deep Dive “Scaling Innovation in Cardiometabolic & Weight Management".
You’ll also be able to meet the Newel Health team in their Networking Lounge throughout the two-day event.
Join us at FH25 to experience how Newel Health is shaping the next era of digital precision care.